Local Institution

Seattle, Washington 98109

0 studies enrolling now · 23 studies all time

What they study most

Alzheimer Disease, Bipolar Disorder, Bladder Cancer, Bladder Neoplasms, Blast Crisis, Chronic Myeloid Leukemia, Deep-Vein Thrombosis, Dyslipidemia, Essential Thrombocythemia, HIV Infections, Kawasaki Disease, Kidney Neoplasms

Studies at this site

• A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder — Completed
• Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003) — Completed
• An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma — Completed
• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis — Stopped early
• Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis — Completed
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder — Completed
• Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type — Completed
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Aripiprazole Open-Label, Safety and Tolerability Study — Completed
• Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen — Completed
• CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI — Completed
• Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
• ATV/Ritonavir Nevirapine Interaction (USPAC) — Completed
• Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed
• Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study — Completed
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed